A combination of two existing chemotherapy drugs has been used to fight bladder cancer successfully for the first time in ...
JNJ's regulatory filing seeks the FDA's approval for TAR-200, a drug-device combination for treating certain bladder cancer ...
J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback